CNS & Neurological Disorders - Drug Targets

CNS & Neurological Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5273
ISSN (Online): 1996-3181

Back Subscribe
Research Article

Chlorogenic Acid as a Neuroprotective Agent: Enhancing Plasticity and Promoting Brain Health and Functional Reserve

Author(s): Elizabeth Hernandez-Echeagaray*orcid of author, Ruben Vazquez-Roque, Julio Cesar Morales-Medina, Francisco M. Torres-Cruz, Elibeth Monroy, Gumaro Galindo-Paredes, Gabriel Gutierrez-Ospina and Gonzalo Flores

Volume 25, Issue 2, 2026

Published on: 27 February, 2025

Page: [139 - 152] Pages: 14

DOI: 10.2174/0118715273339375250116042441

Price: $65

Become a Editorial Board Member
Become a Reviewer
Become a Editor
Become a Section Editor

Abstract

Introduction: Functional reserve, the process that warrants the brain to have resources to maintain key functions and processes when facing neurodegeneration, may be strengthened in nominally healthy subjects by measures that prompt neural plasticity throughout life.

Methods: In this work, we administered Chlorogenic Acid (CGA) to evaluate its ability to promote functional morphological plasticity in the frontal cortical-striatal circuit of healthy mice, a pathway exposed constantly to oxidative challenges, excitotoxicity, and neuroinflammation. The magnitude of neural plasticity was estimated by assessing spontaneous motor behavior (open field), the relative magnitude of neuronal activation (number of c-Fos positive neurons), dendritic remodeling (Golgi- Cox impregnation), the availability of Brain-Derived Neurotrophic Factor (BDNF) (semiquantitative Western blotting), and lipid peroxidation (TBARS assay) in CGA- or vehicle-administered C57BL/6 male mice.

Results: CGA administration increased c-Fos in the Dorsal striatum (Ds), changed the availability of BDNF and Pro-BDNF in the Frontal Cortex (FC) and Ds, induced dendritic remodeling in FC and DS neurons, and reduced FC and DS lipid peroxidation without affecting motor performance or the availability of TrkB receptor isoforms.

Conclusion: Our findings suggest that CGA increases functional reserve by promoting neuronal plasticity in healthy male mice. Future research should determine whether these additional resources indeed protect against neurodegeneration.

Keywords: Chlorogenic acid, neuroprotective, neurodegeneration nutraceutics, antioxidants, neurotrophins, polyphenols, plasticity, ProBDNF.

Graphical Abstract

[1]
Lang, A.E. In pursuit of prodromal parkinson’s disease. Lancet Neurol., 2015, 14(1), 27-28.
[http://dx.doi.org/10.1016/S1474-4422(14)70230-3] [PMID: 25435388]
[2]
Landrigan, P.J.; Sonawane, B.; Butler, R.N.; Trasande, L.; Callan, R.; Droller, D. Early environmental origins of neurodegenerative disease in later life. Environ. Health Perspect., 2005, 113(9), 1230-1233.
[http://dx.doi.org/10.1289/ehp.7571] [PMID: 16140633]
[3]
Viel, T.A.; Toricelli, M.; Pereira, A.A.R. Mechanisms of neuroplasticity and brain degeneration: Strategies for protection during the aging process. Neural Regen. Res., 2021, 16(1), 58-67.
[http://dx.doi.org/10.4103/1673-5374.286952] [PMID: 32788448]
[4]
Mitoma, H.; Kakei, S.; Tanaka, H.; Manto, M. Morphological and functional principles governing the plasticity reserve in the cerebellum: The cortico-deep cerebellar nuclei loop model. Biology, 2023, 12(11), 1435.
[http://dx.doi.org/10.3390/biology12111435] [PMID: 37998034]
[5]
Gelfo, F.; Mandolesi, L.; Serra, L.; Sorrentino, G.; Caltagirone, C. The neuroprotective effects of experience on cognitive functions: Evidence from animal studies on the neurobiological bases of brain reserve. Neuroscience, 2018, 370, 218-235.
[http://dx.doi.org/10.1016/j.neuroscience.2017.07.065] [PMID: 28827089]
[6]
Uddin, L.Q. Cognitive and behavioural flexibility: Neural mechanisms and clinical considerations. Nat. Rev. Neurosci., 2021, 22(3), 167-179.
[http://dx.doi.org/10.1038/s41583-021-00428-w] [PMID: 33536614]
[7]
Malliou, F.; Andriopoulou, C.E.; Kofinas, A. Oleuropein promotes neural plasticity and neuroprotection via PPARα-dependent and independent pathways. Biomedicines, 2023, 11(8), 2250.
[http://dx.doi.org/10.3390/biomedicines11082250] [PMID: 37626746]
[8]
Clifford, M.N. Chlorogenic acids and other cinnamates - Nature, occurrence and dietary burden. J. Sci. Food Agric., 1999, 79(3), 362-372.
[http://dx.doi.org/10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D]
[9]
Upadhyay, R.; Mohan Rao, L.J. An outlook on chlorogenic acids-occurrence, chemistry, technology, and biological activities. Crit. Rev. Food Sci. Nutr., 2013, 53(9), 968-984.
[http://dx.doi.org/10.1080/10408398.2011.576319] [PMID: 23768188]
[10]
Hemmerle, H.; Burger, H.J.; Below, P. Chlorogenic acid and synthetic chlorogenic acid derivatives: Novel inhibitors of hepatic glucose-6-phosphate translocase. J. Med. Chem., 1997, 40(2), 137-145.
[http://dx.doi.org/10.1021/jm9607360] [PMID: 9003513]
[11]
Xiang, Z.; Ning, Z. Scavenging and antioxidant properties of compound derived from chlorogenic acid in South-China honeysuckle. Lebensm. Wiss. Technol., 2008, 41(7), 1189-1203.
[http://dx.doi.org/10.1016/j.lwt.2007.08.006]
[12]
Zhang, L.T.; Chang, C.Q.; Liu, Y.; Chen, Z.M. Effect of chlorogenic acid on disordered glucose and lipid metabolism in db/db mice and its mechanism. Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 2011, 33(3), 281-286.
[PMID: 21718611]
[13]
Albarracin, SL; Stab, B; Casas, Z Effects of natural antioxidants in neurodegenerative disease. Nutr Neurosci, 2012, 15(1), 1-9.
[http://dx.doi.org/10.1179/1476830511Y.0000000028] [PMID: 22305647]
[14]
Yun, N.; Kang, J.W.; Lee, S.M. Protective effects of chlorogenic acid against ischemia/reperfusion injury in rat liver: Molecular evidence of its antioxidant and anti-inflammatory properties. J. Nutr. Biochem., 2012, 23(10), 1249-1255.
[http://dx.doi.org/10.1016/j.jnutbio.2011.06.018] [PMID: 22209001]
[15]
Zhao, Y.; Wang, J.; Ballevre, O.; Luo, H.; Zhang, W. Antihypertensive effects and mechanisms of chlorogenic acids. Hypertens. Res., 2012, 35(4), 370-374.
[http://dx.doi.org/10.1038/hr.2011.195] [PMID: 22072103]
[16]
Shi, H.; Dong, L.; Jiang, J. Chlorogenic acid reduces liver inflammation and fibrosis through inhibition of toll-like receptor 4 signaling pathway. Toxicology, 2013, 303, 107-114.
[http://dx.doi.org/10.1016/j.tox.2012.10.025] [PMID: 23146752]
[17]
Wan, C.W.; Wong, C.N.Y.; Pin, W.K. Chlorogenic acid exhibits cholesterol lowering and fatty liver attenuating properties by up-regulating the gene expression of PPAR-α in hypercholesterolemic rats induced with a high-cholesterol diet. Phytother. Res., 2013, 27(4), 545-551.
[http://dx.doi.org/10.1002/ptr.4751] [PMID: 22674675]
[18]
Onakpoya, I.J.; Spencer, E.A.; Thompson, M.J.; Heneghan, C.J. The effect of chlorogenic acid on blood pressure: A systematic review and meta-analysis of randomized clinical trials. J. Hum. Hypertens., 2015, 29(2), 77-81.
[http://dx.doi.org/10.1038/jhh.2014.46] [PMID: 24943289]
[19]
Alarcón-Herrera, N.; Flores-Maya, S.; Bellido, B. Protective effects of chlorogenic acid in 3-nitropropionic acid induced toxicity and genotoxicity. Food Chem. Toxicol., 2017, 109(Pt 2), 1018-1025.
[http://dx.doi.org/10.1016/j.fct.2017.04.048] [PMID: 28478101]
[20]
He, X.; Zheng, S.; Sheng, Y. Chlorogenic acid ameliorates obesity by preventing energy balance shift in high‐fat diet induced obese mice. J. Sci. Food Agric., 2021, 101(2), 631-637.
[http://dx.doi.org/10.1002/jsfa.10675] [PMID: 32683698]
[21]
Mikami, Y.; Yamazawa, T. Chlorogenic acid, a polyphenol in coffee, protects neurons against glutamate neurotoxicity. Life Sci., 2015, 139, 69-74.
[http://dx.doi.org/10.1016/j.lfs.2015.08.005] [PMID: 26285175]
[22]
Kwon, S.H.; Lee, H.K.; Kim, J.A. Neuroprotective effects of chlorogenic acid on scopolamine-induced amnesia via anti-acetylcholinesterase and anti-oxidative activities in mice. Eur. J. Pharmacol., 2010, 649(1-3), 210-217.
[http://dx.doi.org/10.1016/j.ejphar.2010.09.001] [PMID: 20854806]
[23]
Lee, K.; Lee, J.S.; Jang, H.J. Chlorogenic acid ameliorates brain damage and edema by inhibiting matrix metalloproteinase-2 and 9 in a rat model of focal cerebral ischemia. Eur. J. Pharmacol., 2012, 689(1-3), 89-95.
[http://dx.doi.org/10.1016/j.ejphar.2012.05.028] [PMID: 22659584]
[24]
Oboh, G.; Agunloye, O.M.; Akinyemi, A.J.; Ademiluyi, A.O.; Adefegha, S.A. Comparative study on the inhibitory effect of caffeic and chlorogenic acids on key enzymes linked to alzheimer’s disease and some pro-oxidant induced oxidative stress in rats’ brain-in vitro. Neurochem. Res., 2013, 38(2), 413-419.
[http://dx.doi.org/10.1007/s11064-012-0935-6] [PMID: 23184188]
[25]
Shah, M.A.; Kang, J.B.; Park, D.J.; Kim, M.O.; Koh, P.O. Chlorogenic acid alleviates neurobehavioral disorders and brain damage in focal ischemia animal models. Neurosci. Lett., 2021, 760, 136085.
[http://dx.doi.org/10.1016/j.neulet.2021.136085] [PMID: 34174343]
[26]
Krakauer, T. The polyphenol chlorogenic acid inhibits staphylococcal exotoxin-induced inflammatory cytokines and chemokines. Immunopharmacol. Immunotoxicol., 2002, 24(1), 113-119.
[http://dx.doi.org/10.1081/IPH-120003407] [PMID: 12022439]
[27]
Kang, T.Y.; Yang, H.R.; Zhang, J. The studies of chlorogenic Acid antitumor mechanism by gene chip detection: the immune pathway gene expression. J. Anal. Methods Chem., 2013, 2013, 1-7.
[http://dx.doi.org/10.1155/2013/617243] [PMID: 23762780]
[28]
Hwang, S.J.; Kim, Y.W.; Park, Y.; Lee, H.J.; Kim, K.W. Anti-inflammatory effects of chlorogenic acid in lipopolysaccharide-stimulated RAW 264.7 cells. Inflamm. Res., 2014, 63(1), 81-90.
[http://dx.doi.org/10.1007/s00011-013-0674-4] [PMID: 24127072]
[29]
Ji, L.; Jiang, P.; Lu, B.; Sheng, Y.; Wang, X.; Wang, Z. Chlorogenic acid, a dietary polyphenol, protects acetaminophen-induced liver injury and its mechanism. J. Nutr. Biochem., 2013, 24(11), 1911-1919.
[http://dx.doi.org/10.1016/j.jnutbio.2013.05.007] [PMID: 24011717]
[30]
Wang, D.; Tian, L.; Lv, H. Chlorogenic acid prevents acute myocardial infarction in rats by reducing inflammatory damage and oxidative stress. Biomed. Pharmacother., 2020, 132, 110773.
[http://dx.doi.org/10.1016/j.biopha.2020.110773] [PMID: 33022535]
[31]
Rebai, O.; Belkhir, M.; Sanchez-Gomez, M.V.; Matute, C.; Fattouch, S.; Amri, M. Differential molecular targets for neuroprotective effect of chlorogenic acid and its related compounds against glutamate induced excitotoxicity and oxidative stress in rat cortical neurons. Neurochem. Res., 2017, 42(12), 3559-3572.
[http://dx.doi.org/10.1007/s11064-017-2403-9] [PMID: 28948515]
[32]
Takeda, H.; Tsuji, M.; Yamada, T. Caffeic acid attenuates the decrease in cortical BDNF mRNA expression induced by exposure to forced swimming stress in mice. Eur. J. Pharmacol., 2006, 534(1-3), 115-121.
[http://dx.doi.org/10.1016/j.ejphar.2006.01.026] [PMID: 16497295]
[33]
Tsai, S.; Chao, C.; Yin, M. Preventive and therapeutic effects of caffeic acid against inflammatory injury in striatum of MPTP-treated mice. Eur. J. Pharmacol., 2011, 670(2-3), 441-447.
[http://dx.doi.org/10.1016/j.ejphar.2011.09.171] [PMID: 21970803]
[34]
Tisch, S.; Silberstein, P.; Limousin-Dowsey, P.; Jahanshahi, M. The basal ganglia: Anatomy, physiology, and pharmacology. Psychiatr. Clin. North Am., 2004, 27(4), 757-799.
[http://dx.doi.org/10.1016/j.psc.2004.06.004] [PMID: 15550292]
[35]
Shepherd, G.M.G. Corticostriatal connectivity and its role in disease. Nat. Rev. Neurosci., 2013, 14(4), 278-291.
[http://dx.doi.org/10.1038/nrn3469] [PMID: 23511908]
[36]
Chatham, C.H.; Frank, M.J.; Badre, D. Corticostriatal output gating during selection from working memory. Neuron, 2014, 81(4), 930-942.
[http://dx.doi.org/10.1016/j.neuron.2014.01.002] [PMID: 24559680]
[37]
Shen, W.; Qi, R.; Zhang, J. Chlorogenic acid inhibits LPS-induced microglial activation and improves survival of dopaminergic neurons. Brain Res. Bull., 2012, 88(5), 487-494.
[http://dx.doi.org/10.1016/j.brainresbull.2012.04.010] [PMID: 22580132]
[38]
Tatem, K.S.; Quinn, J.L.; Phadke, A.; Yu, Q.; Gordish-Dressman, H.; Nagaraju, K. Behavioral and locomotor measurements using an open field activity monitoring system for skeletal muscle diseases. J. Vis. Exp., 2014, (91), 51785.
[http://dx.doi.org/10.3791/51785-v] [PMID: 25286313]
[39]
Tomm, R.J.; Tse, M.T.; Tobiansky, D.J.; Schweitzer, H.R.; Soma, K.K.; Floresco, S.B. Effects of aging on executive functioning and mesocorticolimbic dopamine markers in male Fischer 344 × brown Norway rats. Neurobiol. Aging, 2018, 72, 134-146.
[http://dx.doi.org/10.1016/j.neurobiolaging.2018.08.020] [PMID: 30245243]
[40]
Morales-Medina, J.C.; Juarez, I.; Venancio-García, E. Impaired structural hippocampal plasticity is associated with emotional and memory deficits in the olfactory bulbectomized rat. Neuroscience, 2013, 236, 233-243.
[http://dx.doi.org/10.1016/j.neuroscience.2013.01.037] [PMID: 23357118]
[41]
González-Cano, S.I.; Camacho-Abrego, I.; Diaz, A.; de la Cruz, F.; Morales-Medina, J.C.; Flores, G. Prenatal exposure to propionic acid induces altered locomotion and reactive astrogliosis in male rats. J. Chem. Neuroanat., 2021, 117, 102011.
[http://dx.doi.org/10.1016/j.jchemneu.2021.102011] [PMID: 34384873]
[42]
Morales-Medina, J.C.; Dumont, Y.; Benoit, C.E. Role of neuropeptide Y Y1 and Y2 receptors on behavioral despair in a rat model of depression with co-morbid anxiety. Neuropharmacology, 2012, 62(1), 200-208.
[http://dx.doi.org/10.1016/j.neuropharm.2011.06.030] [PMID: 21803058]
[43]
Curran, T.; Morgan, J.I. Fos: An immediate‐early transcription factor in neurons. J. Neurobiol., 1995, 26(3), 403-412.
[http://dx.doi.org/10.1002/neu.480260312] [PMID: 7775973]
[44]
Hunt, S.P.; Pini, A.; Evan, G. Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature, 1987, 328(6131), 632-634.
[http://dx.doi.org/10.1038/328632a0] [PMID: 3112583]
[45]
Harris, J.A. Using c-fos as a neural marker of pain. Brain Res. Bull., 1998, 45(1), 1-8.
[http://dx.doi.org/10.1016/S0361-9230(97)00277-3] [PMID: 9434195]
[46]
Salery, M.; Godino, A.; Nestler, E.J. Drug-activated cells: From immediate early genes to neuronal ensembles in addiction. Adv. Pharmacol., 2021, 90, 173-216.
[http://dx.doi.org/10.1016/bs.apha.2020.09.006] [PMID: 33706932]
[47]
Paxinos, G.; Franklin, K.B.J. The Mouse Brain in Stereotaxic Coordinates: Compact, 2nd ed; Elsevier Science, 2004.
[48]
Monfil, T.; Vázquez Roque, R.A.; Camacho-Abrego, I. Hyper-response to novelty increases c-Fos expression in the hippocampus and prefrontal cortex in a rat model of schizophrenia. Neurochem. Res., 2018, 43(2), 441-448.
[http://dx.doi.org/10.1007/s11064-017-2439-x] [PMID: 29214513]
[49]
Morales-Medina, J.C.; Rastogi, A.; Mintz, E.; Caldwell, H.K. Increased immediate early gene activation in the basolateral amygdala following persistent peripheral inflammation. Neuroreport, 2020, 31(10), 724-729.
[http://dx.doi.org/10.1097/WNR.0000000000001480] [PMID: 32501889]
[50]
Mendoza, E.; Miranda-Barrientos, J.A.; Vázquez-Roque, R.A. In vivo mitochondrial inhibition alters corticostriatal synaptic function and the modulatory effects of neurotrophins. Neuroscience, 2014, 280, 156-170.
[http://dx.doi.org/10.1016/j.neuroscience.2014.09.018] [PMID: 25241069]
[51]
Vazquez-Roque, R.; Pacheco-Flores, M.; Penagos-Corzo, J.C. The C‐terminal fragment of the heavy chain of the tetanus toxin (Hc‐TeTx) improves motor activity and neuronal morphology in the limbic system of aged mice. Synapse, 2021, 75(6), e22193.
[http://dx.doi.org/10.1002/syn.22193] [PMID: 33141999]
[52]
De la Torre-Iturbe, S.; Vázquez-Roque, R.A.; De la Cruz-López, F.; Flores, G.; Garcés-Ramírez, L. Dendritic and behavioral changes in rats neonatally treated with homocysteine; A proposal as an animal model to study the attention deficit hyperactivity disorder. J. Chem. Neuroanat., 2022, 119, 102057.
[http://dx.doi.org/10.1016/j.jchemneu.2021.102057] [PMID: 34871732]
[53]
Gibb, R.; Kolb, B. A method for vibratome sectioning of Golgi-Cox stained whole rat brain. J. Neurosci. Methods, 1998, 79(1), 1-4.
[http://dx.doi.org/10.1016/S0165-0270(97)00163-5] [PMID: 9531453]
[54]
Flores, G.; Alquicer, G.; Silva-Gómez, A.B. Alterations in dendritic morphology of prefrontal cortical and nucleus accumbens neurons in post-pubertal rats after neonatal excitotoxic lesions of the ventral hippocampus. Neuroscience, 2005, 133(2), 463-470.
[http://dx.doi.org/10.1016/j.neuroscience.2005.02.021] [PMID: 15878241]
[55]
Sholl, D.A.; Uttley, A.M. Pattern discrimination and the visual cortex. Nature, 1953, 171(4348), 387-388.
[http://dx.doi.org/10.1038/171387a0] [PMID: 13036904]
[56]
Ventimiglia, R.; Mather, P.E.; Jones, B.E.; Lindsay, R.M. The neurotrophins BDNF, NT-3 and NT-4/5 promote survival and morphological and biochemical differentiation of striatal neurons in vitro. Eur. J. Neurosci., 1995, 7(2), 213-222.
[http://dx.doi.org/10.1111/j.1460-9568.1995.tb01057.x] [PMID: 7757258]
[57]
Altar, C.A.; Cai, N.; Bliven, T. Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature, 1997, 389(6653), 856-860.
[http://dx.doi.org/10.1038/39885] [PMID: 9349818]
[58]
Conner, J.M.; Lauterborn, J.C.; Yan, Q.; Gall, C.M.; Varon, S. Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. J. Neurosci., 1997, 17(7), 2295-2313.
[http://dx.doi.org/10.1523/JNEUROSCI.17-07-02295.1997] [PMID: 9065491]
[59]
Zuccato, C.; Ciammola, A.; Rigamonti, D. Loss of huntingtin-mediated BDNF gene transcription in Huntington’s disease. Science, 2001, 293(5529), 493-498.
[http://dx.doi.org/10.1126/science.1059581] [PMID: 11408619]
[60]
Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 1976, 72(1-2), 248-254.
[http://dx.doi.org/10.1016/0003-2697(76)90527-3] [PMID: 942051]
[61]
Kruger, N.J. The Bradford method for protein quantitation. Methods Mol. Biol., 1994, 32, 9-15.
[PMID: 7951753]
[62]
Towbin, H.; Staehelin, T.; Gordon, J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc. Natl. Acad. Sci. USA, 1979, 76(9), 4350-4354.
[http://dx.doi.org/10.1073/pnas.76.9.4350] [PMID: 388439]
[63]
Ohkawa, H.; Ohishi, N.; Yagi, K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem., 1979, 95(2), 351-358.
[http://dx.doi.org/10.1016/0003-2697(79)90738-3] [PMID: 36810]
[64]
Dawn-Linsley, M.; Ekinci, F.J.; Ortiz, D.; Rogers, E.; Shea, T.B. Monitoring thiobarbituric acid-reactive substances (TBARs) as an assay for oxidative damage in neuronal cultures and central nervous system. J. Neurosci. Methods, 2005, 141(2), 219-222.
[http://dx.doi.org/10.1016/j.jneumeth.2004.06.010] [PMID: 15661303]
[65]
Naveed, M.; Hejazi, V.; Abbas, M. Chlorogenic acid (CGA): A pharmacological review and call for further research. Biomed. Pharmacother., 2018, 97, 67-74.
[http://dx.doi.org/10.1016/j.biopha.2017.10.064] [PMID: 29080460]
[66]
Miao, M.; Xiang, L. Pharmacological action and potential targets of chlorogenic acid. Adv. Pharmacol., 2020, 87, 71-88.
[http://dx.doi.org/10.1016/bs.apha.2019.12.002] [PMID: 32089239]
[67]
Mansour, A.; Mohajeri-Tehrani, M.R.; Samadi, M. Effects of supplementation with main coffee components including caffeine and/or chlorogenic acid on hepatic, metabolic, and inflammatory indices in patients with non-alcoholic fatty liver disease and type 2 diabetes: A randomized, double-blind, placebo-controlled, clinical trial. Nutr. J., 2021, 20(1), 35.
[http://dx.doi.org/10.1186/s12937-021-00694-5] [PMID: 33838673]
[68]
Zhang, J.; Zhang, D.; McQuade, J.S.; Behbehani, M.; Tsien, J.Z.; Xu, M. c-fos regulates neuronal excitability and survival. Nat. Genet., 2002, 30(4), 416-420.
[http://dx.doi.org/10.1038/ng859] [PMID: 11925568]
[69]
Ito, H.; Sun, X.L.; Watanabe, M.; Okamoto, M.; Hatano, T. Chlorogenic acid and its metabolite m-coumaric acid evoke neurite outgrowth in hippocampal neuronal cells. Biosci. Biotechnol. Biochem., 2008, 72(3), 885-888.
[http://dx.doi.org/10.1271/bbb.70670] [PMID: 18323641]
[70]
Fernandes, M.Y.D.; Dobrachinski, F.; Silva, H.B. Neuromodulation and neuroprotective effects of chlorogenic acids in excitatory synapses of mouse hippocampal slices. Sci. Rep., 2021, 11(1), 10488.
[http://dx.doi.org/10.1038/s41598-021-89964-0] [PMID: 34006978]
[71]
Yang, G.; Fu, Y.; Malakhova, M. Caffeic acid directly targets ERK1/2 to attenuate solar UV-induced skin carcinogenesis. Cancer Prev. Res. (Phila.), 2014, 7(10), 1056-1066.
[http://dx.doi.org/10.1158/1940-6207.CAPR-14-0141] [PMID: 25104643]
[72]
Bathina, S.; Das, U.N. Brain-derived neurotrophic factor and its clinical implications. Arch. Med. Sci., 2015, 6(6), 1164-1178.
[http://dx.doi.org/10.5114/aoms.2015.56342] [PMID: 26788077]
[73]
Mizui, T.; Ishikawa, Y.; Kumanogoh, H.; Kojima, M. Neurobiological actions by three distinct subtypes of brain-derived neurotrophic factor: Multi-ligand model of growth factor signaling. Pharmacol. Res., 2016, 105, 93-98.
[http://dx.doi.org/10.1016/j.phrs.2015.12.019] [PMID: 26747403]
[74]
Yang, B.; Yang, C.; Ren, Q. Regional differences in the expression of brain-derived neurotrophic factor (BDNF) pro-peptide, proBDNF and preproBDNF in the brain confer stress resilience. Eur. Arch. Psychiatry Clin. Neurosci., 2016, 266(8), 765-769.
[http://dx.doi.org/10.1007/s00406-016-0693-6] [PMID: 27094192]
[75]
Gibon, J.; Barker, P.A.; Séguéla, P. Opposing presynaptic roles of BDNF and ProBDNF in the regulation of persistent activity in the entorhinal cortex. Mol. Brain, 2016, 9(1), 23.
[http://dx.doi.org/10.1186/s13041-016-0203-9] [PMID: 26932787]
[76]
Qiao, H.; An, S.C.; Xu, C.; Ma, X.M. Role of proBDNF and BDNF in dendritic spine plasticity and depressive-like behaviors induced by an animal model of depression. Brain Res., 2017, 1663, 29-37.
[http://dx.doi.org/10.1016/j.brainres.2017.02.020] [PMID: 28284898]
[77]
Kojima, M.; Matsui, K.; Mizui, T. BDNF pro-peptide: Physiological mechanisms and implications for depression. Cell Tissue Res., 2019, 377(1), 73-79.
[http://dx.doi.org/10.1007/s00441-019-03034-6] [PMID: 31076872]
[78]
Bruna, B.; Lobos, P.; Herrera-Molina, R.; Hidalgo, C.; Paula-Lima, A.; Adasme, T. The signaling pathways underlying BDNF-induced Nrf2 hippocampal nuclear translocation involve ROS, RyR-Mediated Ca2+ signals, ERK and PI3K. Biochem. Biophys. Res. Commun., 2018, 505(1), 201-207.
[http://dx.doi.org/10.1016/j.bbrc.2018.09.080] [PMID: 30243728]
[79]
Fernández-García, S.; Sancho-Balsells, A.; Longueville, S. Astrocytic BDNF and TrkB regulate severity and neuronal activity in mouse models of temporal lobe epilepsy. Cell Death Dis., 2020, 11(6), 411.
[http://dx.doi.org/10.1038/s41419-020-2615-9] [PMID: 32483154]
[80]
Xu, J.; Farsad, H.L.; Hou, Y. Human striatal glia differentially contribute to AD- and PD-specific neurodegeneration. Nature Aging, 2023, 3(3), 346-365.
[http://dx.doi.org/10.1038/s43587-023-00363-8] [PMID: 36993867]
[81]
Blumenstock, S.; Dudanova, I. Cortical and Striatal Circuits in Huntington’s Disease. Front. Neurosci., 2020, 14, 82.
[http://dx.doi.org/10.3389/fnins.2020.00082] [PMID: 32116525]
[82]
Martel, A.C.; Galvan, A. Connectivity of the corticostriatal and thalamostriatal systems in normal and parkinsonian states: An update. Neurobiol. Dis., 2022, 174, 105878.
[http://dx.doi.org/10.1016/j.nbd.2022.105878] [PMID: 36183947]

Rights & Permissions Print Cite